These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 27380819)

  • 1. Preprocedural but not periprocedural high-sensitive Troponin T levels predict outcome in patients undergoing transcatheter aortic valve implantation.
    Köhler WM; Freitag-Wolf S; Lambers M; Lutz M; Niemann PM; Petzina R; Lutter G; Bramlage P; Frey N; Frank D
    Cardiovasc Ther; 2016 Dec; 34(6):385-396. PubMed ID: 27380819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-Procedural Troponin Elevation and Clinical Outcomes Following Transcatheter Aortic Valve Implantation.
    Koskinas KC; Stortecky S; Franzone A; O'Sullivan CJ; Praz F; Zuk K; Räber L; Pilgrim T; Moschovitis A; Fiedler GM; Jüni P; Heg D; Wenaweser P; Windecker S
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26896474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and prognostic value of myocardial injury during transcatheter aortic valve implantation.
    Yong ZY; Wiegerinck EM; Boerlage-van Dijk K; Koch KT; Vis MM; Bouma BJ; Henriques JP; Cocchieri R; Piek JJ; de Mol BA; Baan J
    Circ Cardiovasc Interv; 2012 Jun; 5(3):415-23. PubMed ID: 22668556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
    Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late survival and heart failure after transcatheter aortic valve implantation.
    Johansson M; Nozohoor S; Bjursten H; Ragnarsson S; Götberg M; Kimblad PO; Zindovic I; Sjögren J
    Asian Cardiovasc Thorac Ann; 2016 May; 24(4):318-25. PubMed ID: 26966020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement.
    Lindman BR; Breyley JG; Schilling JD; Vatterott AM; Zajarias A; Maniar HS; Damiano RJ; Moon MR; Lawton JS; Gage BF; Sintek MA; Aquino A; Holley CL; Patel NM; Lawler C; Lasala JM; Novak E
    Heart; 2015 Sep; 101(17):1382-8. PubMed ID: 26037104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.
    Onorati F; D'Errigo P; Grossi C; Barbanti M; Ranucci M; Covello DR; Rosato S; Maraschini A; Santoro G; Tamburino C; Seccareccia F; Santini F; Menicanti L;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):568-75. PubMed ID: 24263007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study.
    Ciuca C; Tarantini G; Latib A; Gasparetto V; Savini C; Di Eusanio M; Napodano M; Maisano F; Gerosa G; Sticchi A; Marzocchi A; Alfieri O; Colombo A; Saia F
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):332-8. PubMed ID: 26010724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preserved prognostic value of preinterventional troponin T levels despite successful TAVI in patients with severe aortic stenosis.
    Chorianopoulos E; Krumsdorf U; Geis N; Pleger ST; Giannitsis E; Katus HA; Bekeredjian R
    Clin Res Cardiol; 2014 Jan; 103(1):65-72. PubMed ID: 24096554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of renal function in patients with aortic stenosis treated with transcatheter aortic valve replacement.
    Meneguz-Moreno RA; Ramos AI; Siqueira D; de Castro-Filho A; Jatene T; Dias Jeronimo A; Le Bihan D; Moreira A; Arrais M; Abizaid A; Sousa A; Eduardo Sousa J
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):452-459. PubMed ID: 27514499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of acute kidney injury classifications in patients undergoing transcatheter aortic valve implantation: Predictors and long-term outcomes.
    Koifman E; Segev A; Fefer P; Barbash I; Sabbag A; Medvedovsky D; Spiegelstein D; Hamdan A; Hay I; Raanani E; Goldenberg I; Guetta V
    Catheter Cardiovasc Interv; 2016 Feb; 87(3):523-31. PubMed ID: 26268940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Prognostic Value of High-Sensitivity Troponin T Added to N-Terminal Pro Brain Natriuretic Peptide Plasma Levels Before Valve Replacement for Severe Aortic Stenosis.
    Barbieri F; Senoner T; Adukauskaite A; Dobner S; Holfeld J; Semsroth S; Lambert T; Zweiker D; Theurl T; Rainer PP; Schmidt A; Feuchtner GM; Steinwender C; Hoppe UC; Hintringer F; Bauer A; Müller S; Grimm M; Pfeifer BE; Dichtl W
    Am J Cardiol; 2019 Dec; 124(12):1932-1939. PubMed ID: 31699359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preprocedural high-sensitive troponin predicts survival after transcatheter aortic valve implantation (TAVI).
    Frank D; Stark S; Lutz M; Weissbrodt A; Freitag-Wolf S; Petzina R; Rosenberg M; Lutter G; Frey N
    Int J Cardiol; 2013 Nov; 169(3):e38-9. PubMed ID: 24063930
    [No Abstract]   [Full Text] [Related]  

  • 15. "Heart Team" decision making in elderly patients with symptomatic aortic valve stenosis who underwent AVR or TAVI - a look behind the curtain. Results of the prospective TAVI Calculation of Costs Trial (TCCT).
    Kaier K; Gutmann A; Vach W; Sorg S; Siepe M; von Zur Mühlen C; Moser M; Blanke P; Beyersdorf F; Zehender M; Bode C; Reinöhl J
    EuroIntervention; 2015 Nov; 11(7):793-8. PubMed ID: 25499832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Functional Outcomes Associated With Myocardial Injury After Transfemoral and Transapical Transcatheter Aortic Valve Replacement: A Subanalysis From the PARTNER Trial (Placement of Aortic Transcatheter Valves).
    Paradis JM; Maniar HS; Lasala JM; Kodali S; Williams M; Lindman BR; Damiano RJ; Moon MR; Makkar RR; Thourani VH; Babaliaros V; Xu K; Ayele GM; Svensson L; Leon MB; Zajarias A
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1468-1479. PubMed ID: 26404200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline anemia and its impact on midterm outcome after transcatheter aortic valve implantation.
    Seiffert M; Conradi L; Gutwein A; Schön G; Deuschl F; Schofer N; Becker N; Schirmer J; Reichenspurner H; Blankenberg S; Treede H; Schäfer U
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):E44-E52. PubMed ID: 27142257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation.
    Sinning JM; Ghanem A; Steinhäuser H; Adenauer V; Hammerstingl C; Nickenig G; Werner N
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1141-9. PubMed ID: 21087750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-related differences on short- and long-term outcomes of patients undergoing transcatheter aortic valve implantation.
    Katz M; Carlos Bacelar Nunes Filho A; Caixeta A; Antonio Carvalho L; Sarmento-Leite R; Alves Lemos Neto P; Eduardo Koenig São Thiago L; Dias Dourado Oliveira A; Antonio Marino M; Tadeu Tumelero R; Antonio Perin M; Abizaid A; Tarasoutchi F; Sândoli de Brito F;
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):429-436. PubMed ID: 27468953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor mobility predicts adverse outcome better than other frailty indices in patients undergoing transcatheter aortic valve implantation.
    Cockburn J; Singh MS; Rafi NH; Dooley M; Hutchinson N; Hill A; Trivedi U; de Belder A; Hildick-Smith D
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1271-7. PubMed ID: 26119601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.